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Fig. 2. One month after graft placement, aortography shows good flow of contrast medium through graft, 
with no leakage into false lumen. 
since 1969, when Dotter ~ initially inserted stainless 
steel coils as a vascular stent in canine popliteal arter- 
ies. Clinical endovascular placement of straight stent 
grafts for the treatment of aortic dissection has already 
been reported, 4 but placement of these stent grafts was 
limited to sites that did not include the origin of the 
major aortic arterial branches. With the branched graft, 
we succeeded in endovascular repair of type B dissec- 
tion with intimal tear just beyond the left subclavian 
artery. If long-term results are favorable, endovascular 
repair of larger dissections in patients with type B 
dissection would be possible. Careful long-term evalua- 
tion and further improvement in devices and techniques 
will, however, be necessary for extensive clinical use. 
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AN ADJUSTABLE, PERCUTANEOUSLY PLACED HELICAL COIL: CONTROL OF LEFT 
VENTRICULAR FILLING PRESSURE DURING CARDIOPULMONARY BYPASS IN SEVERE LEFT 
VENTRICULAR FAILURE 
Theodor Kotobow, MD, Jeffrey Wang, Matteo Giacomini, MD, and Chiara Reali-Forster, MD, Bethesda, Md. 
We previously reported that closed-chest total cardio- 
pulmonary bypass through peripheral cannulation can be 
performed in sheep with induced ventricular fibrillation 
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for at least 3 days, with immediate recovery of normal 
cardiac and pulmonary function after defibrillation. 1 Key 
to the success of this procedure was the development of a 
percutaneously placed, fixed-size helical coil that is ad- 
vanced to rest within the lumen of the pulmonary artery 
valves and the tricuspid valves to keep them open. This 
allows the retrograde flow of blood from the bronchial 
venous ystem and the thebesian venous flow and from the 
left side of the heart across the lungs (with the heart in 
ventricular fibrillation), decompressing the left side of the 
heart. In this article we describe the design and develop- 
ment of a flow-directed, catheter-mounted helical coil 
system that has an adjustable diameter and is therefore 
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Fig. 1. A, Larger helical coil, not mounted. B, Cross-section of helical coil. C, Smaller helical coil, not 
mounted. D, Helical coil with added control tube. E, Turning control tube decreases or increases diameter 
of helical coil. Linear pull or push of control tube renders pitch of the coil smaller or greater. F, Helical 
coil with added control tube, mounted onto Swan-Ganz catheter, coiled up and ready for insertion through 
introducer sheath. 
capable of inducing various degrees of decompression f
the left side of the heart. Our design allows the percuta- 
neous placement of the coil through a small, peel-away 
introducer system. 
Helical coils are fabricated of Hytrel elastomer (Du 
Pont, Wilmington, Del.) and superelastic nickel-titanium 
(nitinol) alloy. Flat nitinol wire (0.1 × 0.5 mm; (Fort 
Wayne Metals, Fort Wayne, Ind.) is wound around an 
aluminum mandrel of a desired diameter (such as 5 to 10 
mm) at a desired pitch (for example 2 coils/cm) and heat 
set at 480 ° C for 10 minutes. The coil thus formed is fused 
between two flat sheets of 0.125 mm Hytrel elastomer and 
trimmed to a width of 6 to 8 mm. The resulting helical coil 
(Fig. 1, A) is relieved of internal stress by brief immersion 
in a silicone oil bath at 210 ° C while wound onto the same 
mandrel used in the initial forming of the nitinol spring 
and is bonded to a section of thin-walled Hytrel elastomer 
tubing with an internal diameter slightly larger than the 
outside diameter of the flow-directed catheter on which it 
is to be mounted (control tube, Fig. 1, D). Finally, the 
control tube and the helical spring are passed over a 
flow-directed Swan-Ganz catheter (Baxter Healthcare 
Corp., Edwards Div., Irvine, Calif.), and the proximal end 
is firmly atfixed approximately 5 to 8 cm from the inflation 
balloon (Fig. 1, E). For ease of insertion, we also mount o 
the Swan-Ganz catheter a lock (adjustable seal) to keep 
the spring in a fully coiled, partially uncoiled, or fully 
uncoiled position, according to need, and means to flush 
the space between the control tube and the Swan-Ganz 
catheter (Fig. 1, E). All blood-contacting surfaces are 
heparinized with a TDMAC-heparin complex. For the 
study, helical coils were produced in various sizes and 
lengths, ranging from 5 to 10 mm in internal diameter 
(when fully uncoiled) and varying in length (in the fully 
uncoiled position) from 10 to 14 cm. All of those coils 
could be readily uncoiled further to an internal diameter 
of 15 mm or more. 
Preliminary studies were conducted in three adult 
sheep weighing 40 to 50 kg. All animal studies were 
approved by the Animal Care Committee of the National 
Heart, Lung, and Blood Institute. With the animal under 
general anesthesia and paralyzed, we introduced into the 
right external jugular vein a 14F peel-away introducer 
(Cook Critical Care, Inc., Bloomington, Del.) under flu- 
oroscopic guidance. Through the introducer, we passed a 
7F flow-directed Swan-Ganz catheter with the helical coil 
in the fully coiled position (Fig. 2). After it was wedged in 
the pulmonary artery, the control tube was progressively 
uncoiled and advanced at the same time to keep the 
pulmonary artery valve and tricuspid valves partially or 
totally open (Fig. 3). To withdraw the catheter, these steps 
were repeated in reverse order; the control tube was turned 
in the opposite direction to decrease the diameter of the 
helical coil while being progressively withdrawn. When the 
helical coil had returned to its fully coiled position, the entire 
catheter with the coil could be easily withdrawn. 
Coils so fabricated and kept in the fully coiled position 
were easily passed through a 14F introducer sheath. Once 
in position, coils readily uncoiled to the original design 
diameter or larger (in comparison, to pass an uncoiled 8 
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Fig. 2. A, Helical coil (expanded) and separate 14F peel- 
away introducer. B, Helical coil in expanded form, ready to 
be coiled for passage through 14F introducer. C, Helical coil 
m coiled form. ready for passage through 14F introducer. 
mm helical coil percutaneously would require a 24F to 
26F introducer sheath). The passage was smooth, and the 
nitinol reinforcement wire was readily visible under fluo- 
roscopic guidance (Fig. 3). Once in position, uncoiling 
could proceed without fluoroscopic monitoring according 
to observation of markers placed on the control tube and 
the Swan-Ganz catheter and counting of the number of 
turns needed to partially or totally unwind the helical coil 
as desired. We then repeated the placement and retrieved 
the helical coils several times in each sheep. At the end of 
the studies, the animals were killed. 
This innovation overcomes the previously unsolved 
problems of how to insert a large helical coil to rest within 
the lumen of the pulmonary artery vane and the tricuspid 
valve, how to change the diameter of the helical coil while 
it is lodged within the heart to obtain the desired degree 
of valvular insufficiency, and how to readily retrieve the 
helical coil when it is no longer needed. 
Our previous work 1 and current ongoing work with a 
model of partial or total cardiac failure from warm 
myocardial ischemia show that closed-chest partial and 
total cardiopulmonary b pass (demand cardiopulmonary 
Fig. 3. Chest radiograph shows location of uncoiled he- 
lical coil in sheep (dashed lines represent radiolucent 
plastic components of helical coil). 
bypass) can be conducted espite the most severe left 
ventricular failure, including ventricular fibrillation, when 
the left ventricle is decompressed through valves of the 
right side of the heart that are kept partially or totally 
open with a helical coil. Placement of such coils has 
permitted us to sustain left atrial pressure within the 
normal range, high extracorporeal blood flow, and high 
systemic arterial pressure without relying on pharmaco- 
logic agents or counterpulsation. The integrity of lung 
function, and the optimal conditions for myocardial re- 
covery of whatever cause, are thus greatly enhanced. 
We believe that long-term demand cardiopulmonary 
bypass with percutaneous decompression f the left side 
of the heart is well within the capabilities of extracorpo- 
real membrane oxygenation (ECMO) for acute respira- 
tory failure because perfusion lasting for weeks or even 
months is already common. This method of cardiac assis- 
tance is hence well within the realm of practicality, 
because any recovery, of myocardial function is likely to 
occur within the first 5 days of ventricular assistance. 2 This 
method may find acceptance where more conservative 
methods, such as counterpulsation a d systemic vasodila- 
tors or other pharmacologic agents, are deemed no longer 
effective and when consideration is given to the implan- 
tation of a ventricular-assist device. 
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